Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where J. Scott Moncrief is active.

Publication


Featured researches published by J. Scott Moncrief.


Vaccine | 2000

Fragilysin, the enterotoxin from Bacteroides fragilis, enhances the serum antibody response to antigen co-administered by the intranasal route

Richard R. Vines; Samuel S Perdue; J. Scott Moncrief; Danielle Sentz; Lisa Barroso; Rhonda Wright; Tracy D. Wilkins

Fragilysin, an extracellular zinc metalloprotease produced by enterotoxigenic strains of the anaerobic bacterium Bacteroides fragilis, disrupts the paracellular barrier by cleavage of the intercellular proteins between epithelial cells resulting in fluid secretion. Intranasal immunization of mice with fragilysin and co-administered ovalbumin (Ova) resulted in an Ova-specific serum IgG response that was over 18000-fold higher than Ova alone, as well as detectable levels of serum IgA. Serum IgG titers were comparable with those seen when whole cholera toxin was used as the adjuvant, although the responses obtained with fragilysin showed more variability between mice. Metalloproteases to which fragilysin is structurally related were ineffective as mucosal adjuvants. Our results and similar studies with enterotoxins that affect the paracellular barrier suggest that alteration of mucosal permeability may play an important role in the mechanisms of adjuvanticity.


The Clostridia#R##N#Molecular Biology and Pathogenesis | 1997

Molecular Biology of the Clostridium difficile Toxins

J. Scott Moncrief; David M. Lyerly; Tracy D. Wilkins

Publisher Summary It causes a less severe, but more common, form of the disease termed antibiotic associated diarrhea (ADD). Clostridium difficile is now recognized as the primary cause of ADD in the United States. Toxins are the major virulence factors in C. difficile disease. Protection against toxins A and B are consistently found in fecal specimens from patients and experimental animals with the disease. Effective vaccination of experimental animals against the disease requires protection against both toxins. Most of the research on C. difficile disease has focused on purification and characterization of the molecular and biological properties of toxins A and B. Protein fractions attributed to purified toxin erroneously showed lower molecule weight proteins when analyzed by gel electrophoresis. Cloning, sequencing and expression of the toxin genes in Escherichia coli established that toxins A and B are the largest known bacterial toxins and are each composed of a single polypeptide. The toxins covalently modify low molecular weight guanine triphosphate (GTP)-binding proteins that regulate the actin microfilaments. A number of other clostridial enzymes modify the Rho family of proteins by adenosine diphosphate(ADP)-ribosylation.


Archive | 2000

Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines

Tracy Dale Wilkins; David M. Lylerly; J. Scott Moncrief; Danka Pavliakova; Rachel Scheerson; John B. Robbins


Microbial Pathogenesis | 1994

Mutagenesis of the Clostridium difficile toxin B gene and effect on cytotoxic activity

Lisa Barroso; J. Scott Moncrief; David M. Lyerly; Tracy D. Wilkins


Fems Microbiology Letters | 1997

Cloning and characterization of the gene for the metalloprotease enterotoxin of Bacteroides fragilis

James J Kling; Rhonda Wright; J. Scott Moncrief; Tracy D. Wilkins


Archive | 2000

Recombinant toxin A/toxin B vaccine against Clostridium difficile

Tracy Dale Wilkins; David Maxwell Lyerly; J. Scott Moncrief; Limin Zheng; Carol Phelps


Archive | 2002

Methods to produce high levels of C. difficile toxins

Tracy Dale Wilkins; David Maxwell Lyerly; J. Scott Moncrief; Limin Zheng; Carol Phelps


Archive | 2012

Recombinant production of Clostridium difficile Toxin A or Toxin B

Tracy Dale Wilkins; David M. Lylerly; J. Scott Moncrief; Carol Phelps


Archive | 2000

Support proteique recombinant de la toxine a pour vaccins conjugues polysaccharides

Tracy D. Wilkins; David M. Lylerly; J. Scott Moncrief; Danka Pavliakova; Rachel Scheerson; John B. Robbins


Archive | 2000

Vaccin à toxine recombinante A/B contre Clostridium difficile

Tracy Dale Wilkins; David M. Lylerly; J. Scott Moncrief; Limin Zheng; Carol Phelps

Collaboration


Dive into the J. Scott Moncrief's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Danka Pavliakova

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

John B. Robbins

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge